Search - tctmd.com

Displaying 481 - 500 of 566

Sort: Relevancy | Date

News Daily News

Interrupting Anticoagulation? New Guidance Aims to Simplify Periprocedural Decision-Making

January 09, 2017

News Daily News

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

January 09, 2017

News Daily News

New TAVR Guidance Aims to Ease Evaluation, Management of Patients With Aortic Stenosis

January 05, 2017

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

January 04, 2017

News Daily News

Pregnancy Common and Challenging for Female Cardiologists, Survey Finds

January 03, 2017

News Daily News

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

December 02, 2016

Bayesian Statistics: Utility and Interpretation

Presentation TCT 2016

Bayesian Statistics: Utility and Interpretation

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Marc Etienne Jolicoeur

November 01, 2016

Propensity-Matched Analysis: Advantages and Pitfalls

Presentation TCT 2016

Propensity-Matched Analysis: Advantages and Pitfalls

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Tracy Y. Wang

November 01, 2016

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presentation TCT 2016

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Somjot S. Brar

November 01, 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presentation TCT 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul

November 01, 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

News Daily News

FDA Classifies Latest HeartWare VAD Recalls as Class I

Michael O'Riordan

October 24, 2016

News Daily News

FDA-Funded or Not: Final Rule Makeover Means All Research Must Be Registered and Report Results

Yael L. Maxwell

September 23, 2016

News Daily News

Conflicts of Interest Widespread Among Canadian Guideline Writers

August 26, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

The Hornet’s Nest of Data Sharing: Cardiologist-Led Proposals Do Not Necessarily Agree on Timelines, Reviews

August 03, 2016

News Daily News

FDA: Angiographic Catheter Recalled Due to Potential Tip Separation

July 22, 2016

News Daily News

Decline Seen in Readmissions After PCI in the Medicare Population

July 21, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.